NJORD recognized with an award in Novartis collaboration
NJORD wins ‘Novartis Award for Excellence in Litigation’ for its work in a series of EU parallel trade cases for Novartis. These cases were brought against some of the largest European parallel importers, and NJORD emerged victorious.
Novartis, one of the world's largest pharmaceutical companies and a global leader in research and development of new medicines, works with more than 150 law firms and patient specialists worldwide. Once a year, Novartis gathers all its partners for an inspiring seminar, during which four awards are presented to partners who have made a special contribution.
In 2020, NJORD won the ‘Novartis Award for Excellence in Litigation’ for our year-long effort to define the boundaries of legal repackaging of drugs and combat the illegal exploitation of Novartis' trademarks. In the latest award ceremony, NJORD once again secured the major prize. This time, it was for our work in a series of legal cases where we, as one of three law firms, represented Novartis before the EU Court of Justice and won several landmark cases against the largest European parallel importers.
Thomas Ryhl, Attorney and partner at NJORD Law Firm, says: "I am incredibly proud of this fine recognition and the trust Novartis has placed in us. It has been very rewarding to work with such a strong and dedicated team at Novartis. Winning a series of cases at the highest court in Europe cannot be achieved without the full support and valuable insights from the best in the industry. A warm thank you to the entire team at both Novartis and NJORD Law Firm!"